High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

Autor: Almudena Zapatero, Araceli Guerrero, Xavier Maldonado, Ana Álvarez, Carmen González San-Segundo, María Ángeles Cabeza Rodríguez, Josep María Solé, Agustí Pedro Olivé, Francesc Casas, Ana Boladeras, Carmen Martín de Vidales, María Luisa Vázquez de la Torre, Susana Vara, Juan Luis Sanz, Felipe A Calvo

Publikováno v: The Lancet Oncology. 23:671-681

The optimal duration of androgen deprivation combined with high-dose radiotherapy in prostate cancer remains controversial. The DART 01/05 trial was designed to determine whether long-term androgen deprivation is superior to short-term androgen depri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53055bf1e2151c6b7c1d053bdd7c7ab3
https://doi.org/10.1016/s1470-2045(22)00190-5

Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial

Autor: Xavier Maldonado, Carmen Martín de Vidales, Felipe A. Calvo, A. Guerrero, Almudena Zapatero, M.A. Cabeza, Ana Boladeras, Susana Vara, Ana Alvarez, Francesc Casas, Carmen González San Segundo, J.M. Solé, Agustí Pedro Olive, Maria Luisa Vazquez de la Torre

Publikováno v: Radiotherapy and Oncology. 160:115-119

The optimal prognostic value of testosterone following androgen deprivation therapy (ADT) is controversial. We studied the effect of serum testosterone levels on clinical outcome in localized prostate cancer (PCa) treated with ADT and high-dose radio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f9574ac96a1f5af0b3a46d8a7a127bb
https://doi.org/10.1016/j.radonc.2021.04.018

Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group

Autor: Arantxa Eraso, Javier Sanz, Meritxell Mollà, Vicky Reyes, Agustí Pedro, Meritxell Arenas, Evelyn Martinez, Rosa Ballester, Maria José Cambra, Virginia García, Joan Lluis Prades, Josep M. Borras, Manuel Algara

Publikováno v: Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Scientia

Introduction Daily, moderate hypofractionation has become standard treatment for breast cancer following breast-conserving surgery, although substantial variation exists in its use. This paper describes the generation of consensus-based recommendatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c67d88d8ae5b4e8776f6bcfd9fc4397b
https://pubmed.ncbi.nlm.nih.gov/35190961

Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients

Autor: M. Macia, Meritxell Arenas, Josep Maria Escribà, C Jimenez, V Reyes, S. González, J.M. Solé, R. Ballester, Blanca Farrús, M. Mollà, M.J. Cambra, J. Casals, M. Cusidó, M. A. Seguí, Lluis Anglada, F. Moreno, V. García, X. Sanz, Agustí Pedro, Alberto Biete, A. Arcusa

Publikováno v: Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(5)

To evaluate the effect of boost radiotherapy on ipsilateral breast tumor recurrence (IBTR) for ductal carcinoma in situ (DCIS) after breast-conserving surgery and whole breast radiotherapy (WBRT) with or without boost.Retrospective, multicentre study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38c44a86327a91fb16c39e8b0b95b0aa
https://pubmed.ncbi.nlm.nih.gov/31264148

Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study

Autor: M. Algara, Agustí Pedro, J. Solà, Maria Josep Cambra, Maria J. Fuentes-Raspall, Josep M. Borràs, Lluis Anglada, Victòria Tuset, Esther Rubio, Joan Prades, Meritxell Arenas, V. Reyes, A. Eraso, Josep A. Espinàs, Virginia García-Reglero, Blanca Farrús

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
RADIOTHERAPY AND ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Recercat. Dipósit de la Recerca de Catalunya

Background and purpose: Radiation oncology guidelines favour hypofractionated whole-breast radiotherapy (HWBRT) over more conventional schemes in the conservative treatment of breast cancer, but its adoption still varies in clinical practice. This st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e3c9aa0d430907124d34e96a685afb
http://hdl.handle.net/2445/110743